Literature DB >> 22047833

Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy.

Nelson Wolosker1, José Ribas Milanes de Campos, Paulo Kauffman, Laert Andrade de Oliveira, Marco Antonio Soares Munia, Fábio Biscegli Jatene.   

Abstract

OBJECTIVES: Current data do not provide enough information on how quality of life (QoL) evolves over time in cases of endoscopic thoracic sympathectomy (ETS). The purpose of this study was to ascertain whether the immediate improvement in QoL after the surgery was sustained until the fifth postoperative year.
METHODS: This was a prospective, nonrandomized and uncontrolled study. From March 2001 to December 2003, 475 consecutive patients with hyperhidrosis submitted to ETS were included. A QoL questionnaire was applied at the preoperative day, around the 30th postoperative day, and after the fifth year.
RESULTS: After excluding 22 patients who did not answer all the questions, we analyzed 453 patients. Their ages ranged from 11 to 57 years old, with a mean of 25.3 + 7.9 years, including 297 female patients (65.6%). All patients were assessed on three occasions: before surgery, around the 30th postoperative day, and after the fifth postoperative year. The QoL before surgery was considered to be poor or very poor for all patients. The QoL around 30 days after surgery was better in 412 patients (90.9%), the same in 27 patients (6.0%), and worse in 14 patients (3.1%). After 5 years, 409 patients (90.3%) were better, 27 (6.0%) were the same, and 14 (3.1%) were worse. There were no differences between these postoperative times according to the McNemar statistical test.
CONCLUSION: The patients had an immediate improvement in QoL after ETS, and this improvement was sustained until the fifth postoperative year.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22047833     DOI: 10.1016/j.jvs.2011.07.097

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

Review 1.  Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art.

Authors:  Anna Campanati; Stamatis Gregoriou; George Kontochristopoulos; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2015-01-30

2.  Is there any relationship between quality of life and the level of sympathectomy in primary palmar hyperhidrosis? Single-center experience.

Authors:  Mustafa Vedat Dogru; Celal Bugra Sezen; Oguz Girgin; Levent Cansever; Celalettin Ibrahim Kocaturk; Muzaffer Metin; Seyyit Ibrahim Dincer
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-21

3.  Quality of life in patients with primary axillary hyperhidrosis before and after treatment with fractionated microneedle radiofrequency.

Authors:  Bahareh Abtahi-Naeini; Farahnaz Fatemi Naeini; Neda Adibi; Mohsen Pourazizi
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

4.  Thoracic sympathectomy for the treatment of primary axillary hyperhidrosis: systematic review and proportional meta-analysis.

Authors:  Gilmar Felisberto; Antônio José Maria Cataneo; Daniele Cristina Cataneo
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

5.  Elevated social stress levels and depressive symptoms in primary hyperhidrosis.

Authors:  Katharina M Gross; Andrea B Schote; Katja Kerstin Schneider; André Schulz; Jobst Meyer
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

6.  Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years.

Authors:  Nelson Wolosker; Mariana Krutman; Marcelo Passos Teivelis; Rafael Pessanha de Paula; Paulo Kauffman; Jose Ribas Milanez de Campos; Pedro Puech-Leão
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

7.  Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.

Authors:  Sônia Oliveira Lima; João Fernandes Britto Aragão; José Machado Neto; Kaio Bernardes Santos de Almeida; Layla Melize Santos Menezes; Vanessa Rocha Santana
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.